Kelly Mitchell

1.4k total citations
13 papers, 379 citations indexed

About

Kelly Mitchell is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Kelly Mitchell has authored 13 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Cell Biology. Recurrent topics in Kelly Mitchell's work include Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Kelly Mitchell is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Kelly Mitchell collaborates with scholars based in United States, Russia and Canada. Kelly Mitchell's co-authors include Ulrich Steidl, Justin D. Lathia, Daniel J. Silver, Swathi-Rao Narayanagari, Katie Troike, Ashwin Sridharan, Baoxia Dong, Boris Bartholdy, Gaurav S. Choudhary and Andrea López and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Kelly Mitchell

11 papers receiving 377 citations

Peers

Kelly Mitchell
Kathleen S. Ensbey Australia
Eszter Doma Austria
Simone S. Riedel United States
Jens Rüschmann Canada
Sonia Iyer United States
Patrick A. Ozark United States
Andrew Volk United States
Peter Haviernik United States
Christine Günther Germany
Érika Cosset Switzerland
Kathleen S. Ensbey Australia
Kelly Mitchell
Citations per year, relative to Kelly Mitchell Kelly Mitchell (= 1×) peers Kathleen S. Ensbey

Countries citing papers authored by Kelly Mitchell

Since Specialization
Citations

This map shows the geographic impact of Kelly Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Mitchell more than expected).

Fields of papers citing papers by Kelly Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Mitchell. The network helps show where Kelly Mitchell may publish in the future.

Co-authorship network of co-authors of Kelly Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Mitchell. A scholar is included among the top collaborators of Kelly Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Mitchell. Kelly Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Leutenegger, Christian M., Michelle Evason, Jennifer L. Willcox, et al.. (2024). Benzimidazole F167Y polymorphism in the canine hookworm, Ancylostoma caninum: Widespread geographic, seasonal, age, and breed distribution in United States and Canada dogs. International Journal for Parasitology Drugs and Drug Resistance. 24. 100520–100520. 12 indexed citations
2.
Hoellerbauer, Pia, Sonali Arora, Kelly Mitchell, et al.. (2024). FBXO42 activity is required to prevent mitotic arrest, spindle assembly checkpoint activation and lethality in glioblastoma and other cancers. NAR Cancer. 6(2). zcae021–zcae021.
3.
Mitchell, Kelly, et al.. (2023). Reducing Specimen Rejection Rates Using Concentration-Dependent Hemolysis Rejection Thresholds. The Journal of Applied Laboratory Medicine. 8(2). 285–295.
4.
West, Kip A., Sanjay Kumar, Martin Scott, et al.. (2023). BOS-371, a monoclonal antibody against IL1RAP: Characterization in preclinical models of AML.. Journal of Clinical Oncology. 41(16_suppl). 7030–7030. 2 indexed citations
5.
Turaga, Soumya M., Defne Bayık, Daniel J. Silver, et al.. (2022). SerpinB3 drives cancer stem cell survival in glioblastoma. Cell Reports. 40(11). 111348–111348. 21 indexed citations
6.
Chaklader, Malay, Gamze B. Bulut, Kelly Mitchell, et al.. (2022). Endothelial OCT4 is atheroprotective by preventing metabolic and phenotypic dysfunction. Cardiovascular Research. 118(11). 2458–2477. 22 indexed citations
7.
Jimenez‐Pascual, Ana, Kelly Mitchell, Florian A. Siebzehnrübl, & Justin D. Lathia. (2020). FGF2: a novel druggable target for glioblastoma?. Expert Opinion on Therapeutic Targets. 24(4). 311–318. 22 indexed citations
8.
Mitchell, Kelly, Katie Troike, Daniel J. Silver, & Justin D. Lathia. (2020). The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions. Neuro-Oncology. 23(2). 199–213. 47 indexed citations
9.
10.
Mitchell, Kelly, Laura Barreyro, Tihomira I. Todorova, et al.. (2018). IL1RAP potentiates multiple oncogenic signaling pathways in AML. The Journal of Experimental Medicine. 215(6). 1709–1727. 60 indexed citations
11.
Bartholdy, Boris, Kelly Mitchell, Wendy M. McKimpson, et al.. (2017). A myeloid tumor suppressor role for NOL3. The Journal of Experimental Medicine. 214(3). 753–771. 11 indexed citations
12.
Reyna, Denis E., Thomas P. Garner, Andrea López, et al.. (2017). Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia. Cancer Cell. 32(4). 490–505.e10. 120 indexed citations
13.
Liao, Yanling, Munenari Itoh, Hongwen Zhu, et al.. (2014). Human Cord Blood-Derived Unrestricted Somatic Stem Cells Promote Wound Healing and have Therapeutic Potential for Patients with Recessive Dystrophic Epidermolysis Bullosa. Cell Transplantation. 23(3). 303–317. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen S. Ensbey Breakdown of academic impact, for papers by Eszter Doma Breakdown of academic impact, for papers by Simone S. Riedel Breakdown of academic impact, for papers by Jens Rüschmann Breakdown of academic impact, for papers by Sonia Iyer Breakdown of academic impact, for papers by Patrick A. Ozark Breakdown of academic impact, for papers by Andrew Volk Breakdown of academic impact, for papers by Peter Haviernik Breakdown of academic impact, for papers by Christine Günther Breakdown of academic impact, for papers by Érika Cosset
Rankless by CCL
2026